Gene · 4287
Papers3,790
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,790
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Otubain deubiquitinases: Multi-layered regulators of cell fate, development, and stress responses across kingdoms. | iScience | 2026 | 41550777 | PubTator, text mining | PubMed |
| Hypoxia promotes progression of cervical cancer by modulating the ATXN3-enhanced P53 stability or STAT5 phosphorylation. | Cell Death Discov | 2026 | 41507147 | PubTator, text mining | PubMed |
| Altered Glymphatic Network in Spinocerebellar Ataxia: a Multimodal MRI Study Within a Structure-Environment-Function Framework. | Cerebellum | 2026 | 41504997 | PubTator, text mining | PubMed |
| Praja1 E3 ubiquitin ligase and the role it plays in neurodegeneration. | FEBS J | 2026 | 41466523 | PubTator, text mining | PubMed |
| Diffusion along perivascular spaces as a marker for Glymphatic system impairment in spinocerebellar Ataxia type 3. | Neurobiol Dis | 2026 | 41443376 | PubTator, text mining | PubMed |
| Valosin-Containing Protein as a therapeutic target in CAG repeat-driven Spinocerebellar ataxias: Integrative transcriptomic and computational insights. | Comput Biol Chem | 2026 | 41435767 | PubTator, text mining | PubMed |
| Uncommon yet impactful - case-based reflections on rare neurologic disorders. | Neurol Neurochir Pol | 2026 | 41231206 | PubTator, text mining | PubMed |
| Predictive models for ataxia progression and conversion in spinocerebellar ataxia type 1 and 3. | Brain | 2026 | 41150672 | PubTator, text mining | PubMed |
| Large-scale genetic characterization of Parkinson's disease in the African and African admixed populations. | Brain | 2026 | 41058593 | PubTator, text mining | PubMed |
| Ubiquitin signatures on aggregating proteins in neurodegeneration. | Essays Biochem | 2025 | 41837791 | PubTator, text mining | PubMed |
Characteristics of dysarthria in patients with spinocerebellar degeneration and multiple system atrophy: a cross-sectional and longitudinal study using the Frenchay Dysarthria Assessment Second Edition (FDA-2). | Front Neurol | 2025 | 41573400 | PubTator, text mining | PubMed |
Long-term globus pallidus internus deep brain stimulation in a young patient with spinocerebellar ataxia type 3 initially presenting with levodopa-responsive parkinsonism: a 6-year follow-up case report and literature review. | Ther Adv Neurol Disord | 2025 | 41427024 | PubTator, text mining | PubMed |
| Two-year decline in performance on the Cerebellar Cognitive Affective Syndrome Scale in spinocerebellar ataxias. | J Neurol | 2025 | 41379357 | PubTator, text mining | PubMed |
| Ataxin-3 Overexpression via Adeno-associated Viral Vector Injection in the Primate Cerebellum: A Novel Model of Spinocerebellar Ataxia Type 3. | Exp Neurobiol | 2025 | 41162333 | PubTator, text mining | PubMed |
| Role of Repeat Tract Structure and the rs7158733 SNP in Spinocerebellar Ataxia 3. | Int J Mol Sci | 2025 | 41155132 | PubTator, text mining | PubMed |
| Novel MAML2 Fusions in Human Malignancy. | Cancers (Basel) | 2025 | 41097675 | PubTator, text mining | PubMed |
| The genetic landscape of spinocerebellar ataxias in Taiwan: Insights from 876 genetically confirmed cases. | Parkinsonism Relat Disord | 2025 | 41082794 | PubTator, text mining | PubMed |
| Deciphering deubiquitinating enzyme Ataxin-3 as an emerging target for cancer intervention. | Int J Biol Macromol | 2025 | 41057074 | PubTator, text mining | PubMed |
| Repeat Variants, Biomarkers, and Molecular Signatures in Parkinson's Disease: ATXN2, ATXN3, CACNA1A, PRNP, TBP, C9ORF72, TOMM40, APOE, and POLG-A Swedish Perspective. | Int J Mol Sci | 2025 | 41009775 | PubTator, text mining | PubMed |
| Spinocerebellar ataxias masquerading as movement disorders: clinical and genetic characterization. | Front Neurol | 2025 | 41001200 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4287/papers?page=4